HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

bivatuzumab mertansine

CD44v6-targeting humanized monoclonal antibody coupled to the toxin mertansine for treatment of squamous cell carcinoma of the head and neck
Also Known As:
BIWI 1 compound
Networked: 2 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hanft, Gertraud: 2 articles (09/2008 - 04/2007)
2. Schroen, Carsten: 1 article (09/2008)
3. Golze, Wolfram: 1 article (09/2008)
4. Erhardt, Thomas: 1 article (09/2008)
5. Hoermann, Karl: 1 article (09/2008)
6. Sauter, Alexander: 1 article (09/2008)
7. Gronau, Silke: 1 article (09/2008)
8. Riechelmann, Herbert: 1 article (09/2008)
9. Sinn, Hans-Peter: 1 article (04/2007)
10. Schneeweiss, Andreas: 1 article (04/2007)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Toxic Epidermal Necrolysis (Lyell's Syndrome)
3. Squamous Cell Carcinoma (Epidermoid Carcinoma)

Related Drugs and Biologics

1. Immunoconjugates (Immunoconjugate)
2. taxane